Health Psychol Rev
September 2025
Beliefs about illness powerfully shape how people experience and respond to health conditions. The dominant theory underpinning illness perception - Leventhal's Common-Sense Model - proposes that individuals construct cognitive representations of illness based on specific beliefs about its features and likely course (e.g.
View Article and Find Full Text PDFSurvivors of major catastrophes face significant mental health risks but may also experience growth in meaning, relationships, and self-esteem. Two years after the onset of the Coronavirus disease 2019 (COVID-19) pandemic, we conducted a randomized clinical trial to test the effects of an intervention that promotes the mindset that "catastrophes can be opportunities in the long-term" on mental health and well-being. Adults were randomized to a mindset intervention (n = 226) or control group (n = 153).
View Article and Find Full Text PDFBackground: Patients' negative expectations about medication can exacerbate side effect burden leading to low adherence and persistence. A novel intervention involves targeting mindsets about non-severe symptoms; reframing them as encouraging signs of medication working.
Purpose: This study aimed to assess whether a brief symptom-mindset intervention can improve symptom experience and adherence in patients starting methotrexate to treat an inflammatory rheumatic disease.
Health Psychol
February 2025
Background: Side-effect concerns are a major barrier to vaccination against COVID-19 and other diseases. Identifying cost- and time-efficient interventions to improve vaccine experience and reduce vaccine hesitancy-without withholding information about side effects-is critical.
Purpose: Determine whether a brief symptom as positive signals mindset intervention can improve vaccine experience and reduce vaccine hesitancy after the COVID-19 vaccination.
Objective: To explore whether family-centered communication impacts decisions and optimizes patient-companion-provider consultations.
Methods: A parallel, two-arm randomized controlled trial was conducted with 108 participants acting as patients with inflammatory arthritis or companions. Pairs attended a mock consultation where a physician explained the change from a bio-originator to a biosimilar using family-centered or patient-only communication.